Aditi Tandon
Tribune News Service
New Delhi, June 29
About the therapy
-
Convalescent plasma of recovered patients can potentially mitigate Covid
-
Nod to trials of India’s 1st Covid vaccine candidate
On a day when Delhi became the first state in the country to announce the establishment of convalescent plasma bank to manage Covid patients, the Centre issued a cautionary advisory saying the efficacy of plasma therapy had not yet been established and was still at trial stage.
The National Blood Transfusion Council issued renewed guidelines on the subject: “The treatment of patients using convalescent plasma is under trial and currently no evidence of efficacy of convalescent plasma as a treatment modality has been established.” The council, however, asked blood banks across India to keep systems in place to enable cured patients to return as donors for convalescent plasma once the efficacy of the treatment was established. The guidelines came parallel to Maharashtra launching the largest convalescent plasma therapy trial in India.
The Covid cases in India today neared 5.5 lakh as per the morning updates issued by the Ministry of Health.
Join Whatsapp Channel of The Tribune for latest updates.